In Vivo mouse imaging and spectroscopy in drug discovery
Open Access
- 24 April 2007
- journal article
- review article
- Published by Wiley in NMR in Biomedicine
- Vol. 20 (3) , 154-185
- https://doi.org/10.1002/nbm.1153
Abstract
Imaging modalities such as micro‐computed tomography (micro‐CT), micro‐positron emission tomography (micro‐PET), high‐resolution MRI, optical imaging, and high‐resolution ultrasound have become invaluable tools in preclinical pharmaceutical research. They can be used to non‐invasively investigate, in vivo, rodent biology and metabolism, disease models, and pharmacokinetics and pharmacodynamics of drugs. The advantages and limitations of each approach usually determine its application, and therefore a small‐rodent imaging laboratory in a pharmaceutical environment should ideally provide access to several techniques. In this paper we aim to illustrate how these techniques may be used to obtain meaningful information for the phenotyping of transgenic mice and for the analysis of compounds in murine models of disease. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 100 references indexed in Scilit:
- Differential Compartmentalization and Distinct Functions of GABAB Receptor VariantsNeuron, 2006
- Prenatal evaluation of kidney function in mice using dynamic contrast-enhanced magnetic resonance imagingBrain Structure and Function, 2005
- Magnetic resonance imaging of coronary arteries, the ischemic cascade, and myocardial infarctionAmerican Heart Journal, 2005
- Current status of cardiac MRI in small animalsMagnetic Resonance Materials in Physics, Biology and Medicine, 2004
- Volumetric analysis of mice lungs in a clinical magnetic resonance imaging scannerMagnetic Resonance Materials in Physics, Biology and Medicine, 2004
- Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesisNeurobiology of Aging, 2004
- MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's diseaseMagnetic Resonance in Medicine, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industryCurrent Opinion in Pharmacology, 2003
- Increased Uncoupling Protein2 mRNA in White Adipose Tissue, and Decrease in Leptin, Visceral Fat, Blood Glucose, and Cholesterol in KK-AyMice Fed with Eicosapentaenoic and Docosahexaenoic Acids in Addition to Linolenic AcidBiochemical and Biophysical Research Communications, 1999